. There are so many drugs out there," Griffin said. "I personally think that the best thing would be to get rid of the 50-milligram dose, or sell it only in packages of five.
"You hate to make people jump through hoops to get things but it should be harder to prescribe drugs that would potentially do harm."
Others who contributed to the Vanderbilt study were Patrick G. Arbogast, Ph.D., assistant professor of Preventive Medicine; James R. Daugherty, M.S., computer systems analyst in the department; and David J. Graham, M.D., of the U.S. Food and Drug Administration.
Griffin consults for Merck Research Laboratories, part of Merck & Co., Inc., which makes Vioxx, but none of the funding for this study was provided by Merck or any other pharmaceutical company.
Page: 1 2 3 Related biology news :1
Contact: Clinton Colmenares
Vanderbilt University Medical Center
. PTEN and prostate cancer--the devil is in the doses2
. Research shows high doses of acetaminophen clear rapidly and consistently from bloodstream3
. UT Southwestern researchers say overdoses of acetaminophen cause most cases of acute liver failure4
. Extended-release niacin effective in low doses for diabetics, say UT Southwestern researchers5
. Low doses of radiation in nature may pose more risk6
. Gel may cut doses for some medications7
. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds8
. Pollutant causes delayed flowering in plants9
. Disruption of protein-folding causes neurodegeneration, mental retardation10
. Researchers discover why mutant gene causes colon cancer11
. Analysis fingers causes of desertification